Correlation Between Cabio Biotech and Cansino Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cabio Biotech and Cansino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cabio Biotech and Cansino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cabio Biotech Wuhan and Cansino Biologics, you can compare the effects of market volatilities on Cabio Biotech and Cansino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabio Biotech with a short position of Cansino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabio Biotech and Cansino Biologics.

Diversification Opportunities for Cabio Biotech and Cansino Biologics

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cabio and Cansino is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cabio Biotech Wuhan and Cansino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cansino Biologics and Cabio Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabio Biotech Wuhan are associated (or correlated) with Cansino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cansino Biologics has no effect on the direction of Cabio Biotech i.e., Cabio Biotech and Cansino Biologics go up and down completely randomly.

Pair Corralation between Cabio Biotech and Cansino Biologics

Assuming the 90 days trading horizon Cabio Biotech Wuhan is expected to under-perform the Cansino Biologics. In addition to that, Cabio Biotech is 1.52 times more volatile than Cansino Biologics. It trades about -0.4 of its total potential returns per unit of risk. Cansino Biologics is currently generating about -0.41 per unit of volatility. If you would invest  6,755  in Cansino Biologics on October 12, 2024 and sell it today you would lose (1,045) from holding Cansino Biologics or give up 15.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cabio Biotech Wuhan  vs.  Cansino Biologics

 Performance 
       Timeline  
Cabio Biotech Wuhan 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cabio Biotech Wuhan has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Cabio Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Cansino Biologics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cansino Biologics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cansino Biologics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Cabio Biotech and Cansino Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cabio Biotech and Cansino Biologics

The main advantage of trading using opposite Cabio Biotech and Cansino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabio Biotech position performs unexpectedly, Cansino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cansino Biologics will offset losses from the drop in Cansino Biologics' long position.
The idea behind Cabio Biotech Wuhan and Cansino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities